To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1879
Peptide Name Sequence 15 from Patent CN116964073 A
Sequence NLNDRLASLYDKV
Sequence Length 13
Source Synthetic construct
Target Organism SARS-CoV-2,MERS-CoV,BCoV,H1N11
Patent Type Patent Application
Publication Date 2023-10-27
Patent No CN116964073 A
Patent Title Peptides for treating respiratory tract infections of viral origin
Comment
Abstract A peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 2 to SEQ ID NO: 20, and a pharmaceutical composition comprising the peptide. A pharmaceutical composition for treating or preventing infections caused by viruses infecting respiratory epithelial cells of mammals, comprising a peptide having the amino acid sequence identified as SEQ ID NO: 1. The invention comprises the use of a peptide having an amino acid sequence identified as SEQ ID NO: 1 to SEQ ID NO: 20 for the preparation of a medicament for the treatment or prevention of infections caused by viruses infecting epithelial cells of the respiratory system of a mammal. Also disclosed is a combination of at least one peptide identified as the amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 30 and an antiviral drug.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.